Disitamab Vedotin Combined With Cisplatin for Neoadjuvant Therapy in Locally Advanced Cervical Cancer: a Prospective, Single-arm Clinical Trial
Latest Information Update: 04 Apr 2025
At a glance
- Drugs Disitamab vedotin (Primary) ; Cisplatin
- Indications Cervical cancer; Squamous cell cancer
- Focus Therapeutic Use
Most Recent Events
- 01 Apr 2025 Status changed from not yet recruiting to recruiting.
- 22 Oct 2024 Planned initiation date changed from 1 Oct 2024 to 20 Oct 2024.
- 22 Aug 2024 New trial record